Their stock is up.  Their profits are way up.  They are making money hand over fist.  I can tell you the why of it too.  They now cover fewer drugs, they routinely deny drugs to patients, and they raised the co-pay at least 15%.  Can’t help but make a profit when you gouge more and spend less.

     The Chairman and CEO, age 55, makes a whopping $1,300,000 yearly salary.  I’m betting that if he needs a drug for some illness, he doesn’t have to worry about how to pay for it.  The President and COO, Age 56, makes a tidy $810,872 a year.  He doesn’t worry either.  The SVP Finance and CFO, Age 52, makes $548,560 a year, another one who has no worries about where he’d find the money to pay for a prescription.

     Yowza, if we had that sort of money coming in each year we wouldn’t worry either.  Ampyra is a new drug.  It is a costly drug.  Why would they want to nick their profit margin a bit?  They live well.  They have no worries.  Why bother helping out the little guy?

     DH’s neurologists want him on Ampyra.  It’s a quality of life thing.  DH struggles to walk every day.  Some days he walks better than other days.  However, now it is summer and the heat (especially the record-breaking heat we’re having) makes him worse.  Guaranteed, if Mr. Chairman and CEO with the $1,300,000 yearly salary had the same problem, he’d get Ampyra tomorrow.